Recent mechanistic combinatorial targeted therapy approaches, such as double inhibition of IGF1R and ERK signaling in organoid models, display increased sensitivity of pancreatic tumors to autophagy inhibitors such as hydroxychloroquine [66] and serve as a precedence to our concept. The gene discussed is IGF1R; the disease is pancreatic neoplasm.